文献速递神经头颈MR

动态磁敏感对比灌注MRI在脑转移瘤放射性坏死与新生血管鉴别诊断中的应用:基于rCBV、rCBF与K2的评估

Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
PubMed 文献 · Radiol Med · 2018-03-05

回顾性纳入29例经化疗或放疗的继发性脑肿瘤患者,于3个月随访时行DSC灌注MRI,测量rCBV、rCBF与K2。复发组rCBV均值4.28(标准差2.09)高于坏死相关改变组0.77(标准差0.44)。rCBV取2.1时诊断准确率达100%(敏感度100%、特异度100%)。

要点

  • rCBV取2.1作为阈值时,鉴别复发与放射性坏死的敏感度和特异度均为100%。
  • 复发组rCBV均值4.28(标准差2.09)高于坏死组0.77(标准差0.44)。
  • rCBV与rCBF在两组间差异有统计学意义(p<0.05),K2未报告显著差异。

核心结论

  • DSC-MRI似乎是有助于鉴别脑转移瘤治疗后肿瘤复发、肿瘤坏死与假性进展的临床实用方法,rCBV取2.1时最为准确可靠。

研究设计与样本

  • 回顾性研究,纳入29例继发性脑肿瘤患者,行DSC灌注MRI并于化疗或放疗后3个月随访成像,以组织学检查或临床-影像随访为参考标准分为复发组与稳定组。

关键影像表现/征象

  • 在强化病灶周围勾画感兴趣区,测量rCBV、rCBF与K2。
  • 复发组rCBV均值4.28(标准差2.09),坏死相关改变组均值0.77(标准差0.44)。

诊断标准与关键数值

  • rCBV取2.1为阈值时诊断准确率100%,敏感度100%,特异度100%。
  • rCBV与rCBF在复发与无病生存患者间差异有统计学意义(p<0.05)。

临床应用与阅片要点

  • 对脑转移瘤放疗或化疗后3个月随访的强化病灶,可测量rCBV辅助鉴别肿瘤复发与放射性坏死。
  • rCBV取2.1时在本研究中诊断准确率最高,但原文未报告该阈值在其他人群的验证结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: Distinction between treatment-related changes and tumour recurrence in patients who have received radiation treatment for brain metastases can be difficult on conventional MRI. In this study, we investigated the ability of dynamic susceptibility contrast (DSC) perfusion in differentiating necrotic changes from pathological angiogenesis and compared measurements of relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF) and K2, using a dedicated software.

METHODS: Twenty-nine patients with secondary brain tumors were included in this retrospective study and underwent DSC perfusion MRI with a 3-month follow-up imaging after chemo- or radiation-therapy. Region-of-interests were drawn around the contrast enhancing lesions and measurements of rCBV, rCBF and K2 were performed in all patients. Based on subsequent histological examination or clinico-radiological follow-up, the cohort was divided in two groups: recurrent disease and stable disease. Differences between the two groups were analyzed using the Student's t test. Sensitivity, specificity and diagnostic accuracy of rCBV measurements were analyzed considering three different cut-off values.

RESULTS: Between patients with and without disease, only rCBV and rCBF values were significant (p < 0.05). The only cut-off value giving the best diagnostic accuracy of 100% was rCBV = 2.1 (sensitivity = 100%; specificity = 100%). Patients with tumor recurrence showed a higher mean value of rCBV (mean = 4.28, standard deviation = 2.09) than patients with necrotic-related changes (mean = 0.77, standard deviation = 0.44).

CONCLUSION: DSC-MRI appears a clinically useful method to differentiate between tumor recurrence, tumor necrosis and pseudoprogression in patients treated for cerebral metastases. Relative CBV using a cut-off value of 2.1 proved to be the most accurate and reliable parameter.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Muto M, Frauenfelder G, Senese R, et al. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2. Radiol Med. 2018. PMID: 29508242. doi:10.1007/s11547-018-0866-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。